Syra Health to Present at NobleCon20
Syra Health (NASDAQ: SYRA) announced its participation in the Noble Financial Capital Markets 20th Annual Equity Conference (NobleCon20) scheduled for December 3-4 in Boca Raton, Florida. CEO Dr. Deepika Vuppalanchi will present on December 3 at 2:00 p.m. ET, showcasing the company's healthcare solutions focused on mental health crisis, chronic conditions, and child welfare challenges.
The presentation will be followed by a fireside chat and one-on-one investor meetings. CFO Priya Prasad will also attend the event. The company reports strong revenue growth and expanding market presence, positioning itself to meet increasing demand for innovative healthcare solutions.
Syra Health (NASDAQ: SYRA) ha annunciato la sua partecipazione al 20° Annual Equity Conference di Noble Financial Capital Markets (NobleCon20), previsto per il 3-4 dicembre a Boca Raton, Florida. Il CEO Dr. Deepika Vuppalanchi presenterà il 3 dicembre alle 14:00 ET, illustrando le soluzioni sanitarie dell'azienda focalizzate sulla crisi della salute mentale, sulle condizioni croniche e sulle sfide nel benessere infantile.
La presentazione sarà seguita da una chiacchierata informale e da incontri individuali con gli investitori. Anche il CFO Priya Prasad parteciperà all'evento. L'azienda riporta una forte crescita dei ricavi e un'ampia presenza nel mercato, posizionandosi per soddisfare la crescente domanda di soluzioni sanitarie innovative.
Syra Health (NASDAQ: SYRA) anunció su participación en la 20ª Conferencia Anual de Capital de Noble Financial Markets (NobleCon20), programada para el 3 y 4 de diciembre en Boca Raton, Florida. La CEO, Dra. Deepika Vuppalanchi, presentará el 3 de diciembre a las 2:00 p.m. ET, mostrando las soluciones de atención médica de la empresa centradas en crisis de salud mental, condiciones crónicas y retos en el bienestar infantil.
La presentación será seguida por una charla informal y reuniones individuales con inversores. La CFO Priya Prasad también asistirá al evento. La compañía informa de un sólido crecimiento de ingresos y una creciente presencia en el mercado, posicionándose para satisfacer la demanda en aumento de soluciones de atención médica innovadoras.
Syra Health (NASDAQ: SYRA)는 플로리다 주 보카 러톤에서 12월 3-4일에 예정된 노블 파이낸셜 캐피탈 마켓 20회 연례 주식 컨퍼런스 (NobleCon20)에 참가한다고 발표했습니다. CEO Dr. Deepika Vuppalanchi는 12월 3일 오후 2시에 발표하여 정신 건강 위기, 만성 질환, 아동 복지 문제에 중점을 둔 회사의 의료 솔루션을 소개할 예정입니다.
발표 이후에는 자유로운 대화 시간을 가지며, 일대일 투자자 미팅도 예정되어 있습니다. CFO Priya Prasad도 이 행사에 참석합니다. 회사는 강력한 수익 성장과 시장 존재감 확대를 보고하고 있으며, 혁신적인 의료 솔루션에 대한 증가하는 수요를 충족할 수 있도록 포지셔닝하고 있습니다.
Syra Health (NASDAQ: SYRA) a annoncé sa participation à la 20e Conférence Annuelle sur les Actions de Noble Financial Capital Markets (NobleCon20), prévue les 3 et 4 décembre à Boca Raton, Floride. Le PDG Dr. Deepika Vuppalanchi présentera le 3 décembre à 14h00 ET, mettant en avant les solutions de santé de l'entreprise axées sur la crise de la santé mentale, les maladies chroniques et les défis du bien-être des enfants.
La présentation sera suivie d'une discussion informelle et de réunions individuelles avec les investisseurs. La CFO Priya Prasad assistera également à l'événement. L'entreprise rapporte une forte croissance des revenus et une présence croissante sur le marché, se positionnant pour répondre à la demande croissante de solutions de santé innovantes.
Syra Health (NASDAQ: SYRA) hat seine Teilnahme an der 20. jährlichen Eigenkapitalkonferenz von Noble Financial Capital Markets (NobleCon20), die für den 3. und 4. Dezember in Boca Raton, Florida, geplant ist, bekannt gegeben. CEO Dr. Deepika Vuppalanchi wird am 3. Dezember um 14:00 Uhr ET präsentieren und dabei die Gesundheitslösungen des Unternehmens präsentieren, die sich auf Krisen im Bereich der psychischen Gesundheit, chronische Erkrankungen und Herausforderungen im Bereich des Kindeswohls konzentrieren.
Der Präsentation folgt ein informelles Gespräch sowie Einzelgespräche mit Investoren. CFO Priya Prasad wird ebenfalls an der Veranstaltung teilnehmen. Das Unternehmen meldet ein starkes Umsatzwachstum und eine zunehmende Marktpräsenz, wodurch es sich positioniert, um der steigenden Nachfrage nach innovativen Gesundheitslösungen gerecht zu werden.
- None.
- None.
Syra Health CEO, Dr. Deepika Vuppalanchi, will present at the prestigious event, which highlights emerging growth companies. Dr. Vuppalanchi will deliver the Company's presentation on December 3 at 2:00 p.m. ET. The presentation will highlight Syra Health's healthcare solutions, designed to address the growing mental health crisis, other chronic conditions, and child welfare challenges, while delivering both improved patient outcomes and public health advancements. These innovative approaches are particularly impactful in regions where the demand for accessible, affordable, and high-quality care is rapidly increasing, reflecting Syra's commitment to fostering healthier communities and driving meaningful change.
"We are excited to present Syra Health's innovations at the Noble Conference," said Dr. Vuppalanchi. "This platform provides an excellent opportunity to engage with investors to discuss how our solutions are transforming healthcare, improving outcomes, and driving access and affordability across the system."
Following the presentation, Dr. Vuppalanchi will engage in a fireside chat, offering further insights into Syra Health's strategy and vision for the future. In addition to the presentation and fireside chat, Dr. Vuppalanchi will participate in one-on-one meetings with investors. Syra Health's CFO, Priya Prasad, will also attend the event.
Syra Health's financial outlook is robust, with strong revenue growth and an expanding market presence. The Company is well-positioned to capitalize on the increasing demand for its innovative healthcare solutions and to continue driving value for stakeholders.
ABOUT SYRA HEALTH
Syra Health is a healthcare technology company powering better health in challenging areas such as behavioral and mental health, digital health, and population health, by providing innovative services and technology products. Syra Health's offerings are centered on prevention, improved access, and affordable care. Syra Health supplies its solutions to payers, providers, life sciences organizations, academic institutions, and the government. For more information, please visit www.syrahealth.com.
Forward-Looking Statements
Statements in this press release about future expectations, plans, and prospects, as well as any other statements regarding matters that are not historical facts, may constitute "forward-looking statements." These statements include but are not limited to, statements relating to the expected use of proceeds, the Company's operations and business strategy, and the Company's expected financial results. The words "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "plan," "potential," "predict," "project," "should," "target," "will," "would" and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. The forward-looking statements contained in this press release are based on management's current expectations and are subject to substantial risks, uncertainty, and changes in circumstances. Investors should read the risk factors set forth in our Form 10-K for the year ended December 31, 2023, and other periodic reports filed with the Securities and Exchange Commission. Any forward-looking statements contained in this press release speak only as of the date hereof, and, except as required by federal securities laws, the Company specifically disclaims any obligation to update any forward-looking statements, whether as a result of new information, future events, or otherwise.
For Investor or Media Inquiries:
Christine Drury
IR/PR
Syra Health
463-345-5180
christined@syrahealth.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/syra-health-to-present-at-noblecon20-302317009.html
SOURCE Syra Health
FAQ
When is Syra Health (SYRA) presenting at NobleCon20?
What healthcare solutions will Syra Health (SYRA) discuss at NobleCon20?
Who will represent Syra Health (SYRA) at the Noble Conference 2023?
What is the current financial outlook for Syra Health (SYRA)?
